I
Instituto de Diagnostico ABC | Rosario, Argentina
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Rocatinlimab
Povorcitinib
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 3 total trials
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Active, not recruiting
Atopic Dermatitis
Other: Placebo
Drug: Rocatinlimab
The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function
Enrolling
Moderate to Severe Asthma
Drug: ICS-LABA
Other: placebo
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems